| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 24,938,700 | 25,099,500 | 24,347,200 | 22,925,600 | | Cost of Revenue | 23,537,000 | 23,683,100 | 22,982,700 | 21,456,200 | | | Gross Profit | 1,401,700 | 1,416,400 | 1,364,500 | 1,469,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 850,100 | 851,900 | 882,200 | 901,300 | | Non Recurring | 55,300 | 26,600 | 56,000 | 32,400 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 496,300 | 537,900 | 426,300 | 535,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 496,300 | 537,900 | 426,300 | 535,700 | | Interest Expense | 60,500 | 62,400 | 62,400 | 47,400 | | Income Before Tax | 435,800 | 475,500 | 363,900 | 488,300 | | Income Tax Expense | 122,400 | 156,600 | 114,100 | 166,700 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 313,400 | 318,900 | 249,800 | 321,600 | | | Non-recurring Events | | Discontinued Operations | (600) | (2,400) | (700) | (3,600) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 312,800 | 316,500 | 249,100 | 318,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $312,800 | $316,500 | $249,100 | $318,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
